Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial

2016 ◽  
Vol 1 (2) ◽  
pp. 122-132 ◽  
Author(s):  
Zobair M Younossi ◽  
Maria Stepanova ◽  
Michael Charlton ◽  
Michael P Curry ◽  
Jacqueline G O'Leary ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Patient Reported Outcomes ◽  
Exploratory Analysis ◽  
Decompensated Cirrhosis ◽  
Open Label ◽  
Phase 3 ◽  
Patient Reported

scholarly journals Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir

2018 ◽  
Vol Volume 12 ◽  
pp. 2631-2638 ◽  
Author(s):  
Xinyi Ng ◽  
Chizoba Nwankwo ◽  
Jean Marie Arduino ◽  
Shelby Corman ◽  
Kathryn Eilene Lasch ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Patient Reported Outcomes ◽  
Hepatitis C Virus Infection ◽  
Patient Reported

scholarly journals The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study

2018 ◽  
Vol 7 (3) ◽  
pp. 373-385 ◽  
Author(s):  
Patricia A. M. Kracht ◽  
Faydra I. Lieveld ◽  
Linde M. Amelung ◽  
Carina J. R. Verstraete ◽  
Eveline P. Mauser-Bunschoten ◽  
...  
Keyword(s):  
Cohort Study ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Patient Reported Outcomes ◽  
Direct Acting Antivirals ◽  
Patient Reported ◽  
Direct Acting ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document